Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

The Next Web
Read full post
Reid Hoffman has resigned from Microsoft's board to focus on leading Manus, an AI-driven drug discovery startup. This move marks his shift towards entrepreneurship in the AI healthcare sector.

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes
Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources